ZA200608865B - Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives - Google Patents

Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives

Info

Publication number
ZA200608865B
ZA200608865B ZA200608865A ZA200608865A ZA200608865B ZA 200608865 B ZA200608865 B ZA 200608865B ZA 200608865 A ZA200608865 A ZA 200608865A ZA 200608865 A ZA200608865 A ZA 200608865A ZA 200608865 B ZA200608865 B ZA 200608865B
Authority
ZA
South Africa
Prior art keywords
peptide
vapeehptllteaplnpk
derivatives
biologically active
active peptide
Prior art date
Application number
ZA200608865A
Other languages
English (en)
Inventor
Wai Ming Wong
Kong Lam
Original Assignee
Cms Peptides Patent Holding Company Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cms Peptides Patent Holding Company Ltd filed Critical Cms Peptides Patent Holding Company Ltd
Publication of ZA200608865B publication Critical patent/ZA200608865B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ZA200608865A 2004-04-28 2005-04-25 Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives ZA200608865B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56645504P 2004-04-28 2004-04-28

Publications (1)

Publication Number Publication Date
ZA200608865B true ZA200608865B (en) 2009-06-24

Family

ID=34967983

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200608865A ZA200608865B (en) 2004-04-28 2005-04-25 Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives

Country Status (17)

Country Link
US (1) US7718764B2 (da)
EP (2) EP1756152A2 (da)
JP (1) JP4689664B2 (da)
KR (1) KR101323771B1 (da)
CN (1) CN1976947B (da)
AT (1) ATE505483T1 (da)
AU (1) AU2005238173B2 (da)
CA (1) CA2564179C (da)
DE (1) DE602005027502D1 (da)
DK (1) DK2058328T3 (da)
ES (1) ES2365084T3 (da)
NZ (1) NZ551595A (da)
PT (1) PT2058328E (da)
RU (1) RU2377249C2 (da)
TW (1) TWI353252B (da)
WO (1) WO2005105832A2 (da)
ZA (1) ZA200608865B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11331366B2 (en) 2016-12-05 2022-05-17 Otsuka Pharmaceutical Co., Ltd. Composition for suppressing muscular atrophy
US20230002457A1 (en) * 2019-12-06 2023-01-05 Cooke Aquaculture Inc. Peptides for regulating glucose
CN112812171B (zh) * 2021-01-22 2022-04-08 浙江辉肽生命健康科技有限公司 具有氨基酸结构vvrkplnkegkkp的生物活性肽及其制备方法和应用
US12605349B2 (en) 2024-09-05 2026-04-21 Orbus Therapeutics, Inc. Methods of treating grade 3 astrocytoma

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242821A (en) 1989-07-10 1993-09-07 Valio, Finnish Co-Operative Dairies' Association Lactococcus promoter and signal sequences for expression in bacteria
IT1231156B (it) 1989-07-19 1991-11-19 Eniricerche Spa Espressione e secrezione di interleuchina 1 beta umana matura in bacillus subtilis e mezzi e metodi per il suo ottenimento.
ATE253635T1 (de) 1993-06-15 2003-11-15 Du Pont Rekombinante spinnerseide analoge
JP3286420B2 (ja) 1993-09-28 2002-05-27 株式会社ユニシアジェックス 内燃機関の吸排気弁駆動制御装置
JPH10503643A (ja) 1994-06-17 1998-04-07 ネーデルランセ オルハニサチエ フォール トゥーヘパスト−ナツールウェーテンシャッペルック オンデルズク テーエヌオー 微生物中に遺伝物質を導入する方法およびその方法によってえられる形質転換体
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
IL115199A (en) 1995-09-07 2005-05-17 Opperbas Holding Bv Composition comprising a polynucleic acid molecule in a liposome and method using said composition
EP0867450B1 (en) 1995-10-24 2004-08-11 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute TFPI-related Peptides which inhibit growth of smooth muscle cells
GB9710762D0 (en) * 1997-05-23 1997-07-23 Cancer Res Inst Royal Binding complexes
US6391585B1 (en) 1997-05-27 2002-05-21 Hanil Synthetic Fiber Co., Ltd. Process for preparing recombinant proteins using highly efficient expression vector from saccharomyces cerevisiae
KR19990024297A (ko) 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en) 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US6562958B1 (en) * 1998-06-09 2003-05-13 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics
US6245427B1 (en) 1998-07-06 2001-06-12 DüZGüNES NEJAT Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles
RU2172322C1 (ru) * 1999-12-27 2001-08-20 Энтофарм Ко., Лтд. Аллофероны-иммуномодулирующие пептиды
EP1472276A4 (en) * 2001-02-28 2007-05-09 Keith M Skubitz PEPTIDES OF SMALL SIZE CAPACITY TO MODULATE THE FUNCTION OF THE MEMBERS OF THE FAMILY OF CD66 (CEACAM)
DE10133576A1 (de) * 2001-07-13 2003-01-30 Martin Klingmueller Verwendung von physiologisch aktiven Oligopeptiden zur Stabilisierung des Immunsystems
ATE414099T1 (de) * 2001-07-13 2008-11-15 Cms Peptides Patent Holding Co Biologisch aktive peptide
CN1216072C (zh) * 2001-07-13 2005-08-24 一泰医药研究（深圳）有限公司 序列号5的生物活性肽
WO2004055045A1 (ja) * 2002-12-16 2004-07-01 Caf Laboratories Inc. サルモネラ抗原処方物、それを使用した抗体検査キット及びサブユニットワクチン
WO2004055042A1 (en) * 2002-12-18 2004-07-01 Pepharm R & D Limited Biologically active peptide conjugates

Also Published As

Publication number Publication date
DK2058328T3 (da) 2011-06-27
ES2365084T3 (es) 2011-09-21
ATE505483T1 (de) 2011-04-15
US7718764B2 (en) 2010-05-18
EP2058328B1 (en) 2011-04-13
KR101323771B1 (ko) 2013-10-29
EP1756152A2 (en) 2007-02-28
HK1126790A1 (en) 2009-09-11
TWI353252B (en) 2011-12-01
KR20070004895A (ko) 2007-01-09
CN1976947B (zh) 2010-05-05
AU2005238173B2 (en) 2010-12-23
WO2005105832A2 (en) 2005-11-10
CA2564179C (en) 2013-08-06
PT2058328E (pt) 2011-07-01
RU2377249C2 (ru) 2009-12-27
CN1976947A (zh) 2007-06-06
NZ551595A (en) 2010-04-30
RU2006137699A (ru) 2008-04-27
EP2058328A1 (en) 2009-05-13
US20080125372A1 (en) 2008-05-29
CA2564179A1 (en) 2005-11-10
JP4689664B2 (ja) 2011-05-25
JP2008501642A (ja) 2008-01-24
AU2005238173A1 (en) 2005-11-10
WO2005105832A3 (en) 2006-06-22
DE602005027502D1 (de) 2011-05-26
TW200538151A (en) 2005-12-01

Similar Documents

Publication Publication Date Title
EE04911B1 (et) Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks
BRPI0411241A (pt) agentes terapêuticos úteis para o tratamento de dor
EP1626055A3 (en) Non-mammalian GnRH analogs and uses thereof in the regulation of the immune system
TNSN07020A1 (en) Her2 antibody composition
PE20110102A1 (es) Derivados de n-(2-oxo-2-pirrolidinil-1-il)etil-2-amino-acetamida como inhibidores de proteinas de apoptosis (iap)
RU2010111139A (ru) Комбинированная терапия рака поджелудочной железы с использованием антигенного пептида и химиотерапевтического средства
WO2006034373A3 (en) Variants and chemically-modified variants of phenylalanine ammonia-lyase
UA93043C2 (ru) ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ ДЛЯ ПОЛУЧЕНИЯ ТРАНС-5-ХЛОР-2-МЕТИЛ-2,3,3А,12В-ТЕТРАГИДРО-1Н-ДИБЕНЗ[2,3:6,7]ОКСЕПИНО[4,5-с]ПИРОЛА
EP1614675A3 (en) Amino acids with affinity for the alpha-2-delta protein
WO2005016867A3 (en) Anthranilic acid derivatives and their use as activators of the hm74a receptor
CA2547990A1 (en) Pharmaceutical compositions and methods for insulin treatment
EE200400031A (et) Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat
NI200800216A (es) Uso de compuestos peptídicos de tpo y composiciones farmacéuticas en el tratamiento de la anemia
ATE342264T1 (de) Indolderivate und deren verwendung als gnrh antagonisten
EA200700976A1 (ru) Соединения в виде молекул-конъюгатов, обладающих повышенной активностью в отношении включения клеткой
PT2058328E (pt) Derivados do péptido biologicamente activo vapeehptllteaplnpk
MXPA06003381A (es) Beta aminoacidos terapeuticos.
AU2003267551A1 (en) Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
WO2003092736A3 (en) Peptide nucleic acid conjugates with transporter peptides
JO3684B1 (ar) صور متبلرة من الملح ثنائي الصوديوم لحمض n-(5-كلورو ساليسلويل)-8-امينو كابريليك
WO2007015918A3 (en) Novel biologically active peptides and their new uses
WO2004081031A3 (en) Thiol-mediated drug attachment to targeting peptides
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
GB0229022D0 (en) Organic Compounds
DE602004017062D1 (de) Zusammensetzungen aus deramciclan und opioiden zur verwendung als schmerzmittel